Haleon plc (HLN) Key Metrics

NYSE: HLNValuation, returns, debt and efficiency ratios over 7 years.

HLN key metrics, 2019–2025

Fiscal year ended December 31, 2025 · British pounds

HLN returns How much profit the business earns on the capital it uses.

Return on equity+1.2 pts
10.0%
2025 · hover or tap a bar for each year
2019: 2.4%2020: 4.3% (+1.9 pts)2021: 5.3% (+1.0 pts)2022: 5.0% (−0.3 pts)2023: 6.4% (+1.4 pts)2024: 8.8% (+2.4 pts)2025: 10.0% (+1.2 pts)
20192025
Return on invested capital+1.0 pts
7.9%
2025 · hover or tap a bar for each year
2019: 2.5%2020: 4.4% (+1.9 pts)2021: 5.4% (+1.0 pts)2022: 4.8% (−0.7 pts)2023: 5.3% (+0.6 pts)2024: 6.9% (+1.6 pts)2025: 7.9% (+1.0 pts)
20192025
Return on assets+0.7 pts
4.9%
2025 · hover or tap a bar for each year
2019: 1.8%2020: 3.3% (+1.4 pts)2021: 4.1% (+0.8 pts)2022: 3.1% (−1.0 pts)2023: 3.0% (0.0 pts)2024: 4.2% (+1.2 pts)2025: 4.9% (+0.7 pts)
20192025
Free cash flow margin−0.4 pts
17.9%
2025 · hover or tap a bar for each year
2019: 6.4%2020: 11.0% (+4.6 pts)2021: 11.1% (+0.1 pts)2022: 16.0% (+4.9 pts)2023: 15.6% (−0.4 pts)2024: 18.3% (+2.7 pts)2025: 17.9% (−0.4 pts)
20192025
Cash conversion (OCF / net income)−12.1%
1.40
2025 · hover or tap a bar for each year
2019: 1.202020: 1.23 (+2.4%)2021: 0.98 (−20.6%)2022: 1.95 (+99.5%)2023: 2.00 (+2.9%)2024: 1.60 (−20.3%)2025: 1.40 (−12.1%)
20192025
Asset turnover+0.4%
0.33
2025 · hover or tap a bar for each year
2019: 0.242020: 0.28 (+19.3%)2021: 0.28 (−1.7%)2022: 0.31 (+12.6%)2023: 0.33 (+4.7%)2024: 0.33 (+0.1%)2025: 0.33 (+0.4%)
20192025

HLN returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

HLN debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

HLN cash returned to shareholders

DividendsBuybacksFree cash flow

HLN key metrics in British pounds

2019–2025
Haleon plc key metrics by fiscal year
2025202420232022202120202019
Returns & profitability
Return on equity (ROE)10.0%8.8%6.4%5.0%5.3%4.3%2.4%
Return on invested capital (ROIC)7.9%6.9%5.3%4.8%5.4%4.4%2.5%
Return on assets (ROA)4.9%4.2%3.0%3.1%4.1%3.3%1.8%
Return on tangible assets23.4%17.8%14.6%16.6%19.2%16.6%8.5%
Free cash flow margin17.9%18.3%15.6%16.0%11.1%11.0%6.4%
Income quality (OCF / net income)1.401.602.001.950.981.231.20
Financial health
Total debt£8.59B£10.10B£9.46B£10.44B£991.0M£487.0M£642.0M
Cash & short-term investments£1.32B£2.25B£1.04B£684.0M£414.0M£334.0M£340.0M
Net debt£7.27B£7.85B£8.41B£9.76B£577.0M£153.0M£302.0M
Debt / equity0.520.620.570.640.040.020.02
Debt / assets0.260.290.280.300.030.010.02
Net debt / EBITDA2.532.973.584.470.260.080.26
Current ratio0.920.981.040.931.241.251.36
Quick ratio0.710.780.730.621.011.011.08
Interest coverage7.35.64.85.3102.462.332.0
Working capital−£382.3M−£94.0M£178.0M−£311.0M£1.01B£994.0M£1.54B
Invested capital£23.67B£24.02B£25.02B£26.09B£26.93B£26.27B£27.62B
Tangible asset value−£9.16B−£9.99B−£10.13B−£11.98B−£715.0M−£995.0M−£600.0M
Net current asset value−£11.58B−£12.37B−£12.51B−£14.30B−£2.72B−£2.90B−£2.49B
Capital allocation
Dividends paid£598.6M£570.0M£388.0M£2.68B£1.15B£2.37B£1.15B
Share buybacks (net)£639.7M£121.0M£38.0M£0———
Dividend payout ratio36.7%39.5%37.0%253.0%82.6%207.1%175.9%
Dividends + buybacks / free cash flow62.8%33.7%24.1%154.6%108.5%217.7%212.2%
Capex / revenue2.9%2.2%3.0%3.0%3.1%3.2%2.9%
Capex / operating cash flow13.8%10.9%16.0%15.9%22.0%22.6%30.9%
Capex / depreciation0.890.771.091.141.111.040.93
Stock-based compensation / revenue0.8%0.9%0.8%0.6%−3.9%−7.1%−3.1%
R&D / revenue2.8%2.7%2.8%2.8%2.7%3.1%3.4%
SG&A / revenue39.6%39.6%37.9%37.2%39.7%42.7%42.4%
Efficiency
Days sales outstanding66.652.945.889.398.998.6171.9
Days of inventory on hand105.4110.6115.998.096.599.0120.2
Days payables outstanding271.3163.0155.1145.5172.9170.7188.4
Cash conversion cycle (days)-99.30.56.641.822.526.8103.7
Receivables turnover5.486.907.964.093.693.702.12
Payables turnover1.352.242.352.512.112.141.94
Inventory turnover3.463.303.153.723.783.693.04
Asset turnover0.330.330.330.310.280.280.24
Average receivables£2.01B£1.63B£1.42B£2.66B£2.59B£2.67B£3.99B
Average payables£2.85B£1.91B£1.84B£1.71B£1.70B£1.86B£1.90B
Average inventory£1.11B£1.30B£1.38B£1.15B£950.0M£1.08B£1.21B
Intangibles / total assets78.6%76.4%78.9%81.7%78.9%79.7%78.4%

Computed from HLN's annual financial statements (latest annual report filed March 13, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in British pounds; data from EODHD. Averages use the opening and closing balance of each year.

HLN valuation and financial ratios

Haleon earned a return on equity of 10.0% and a return on invested capital of 7.9% in fiscal 2025. It ended the year with £8.6 billion of debt and £1.3 billion in cash and short-term investments, net debt of £7.3 billion. It returned £1.2 billion to shareholders: £598.6 million in dividends and £639.7 million in share buybacks, 63% of free cash flow.

See the HLN income statement, the HLN chart for price history, or the HLN stock overview for the latest quote and news.

HLN key metrics FAQ

What is Haleon's return on equity?

Haleon's return on equity (ROE) was 10.0% in fiscal 2025: net income of £1.6 billion on average shareholders' equity of £16.3 billion.

What is Haleon's ROIC?

Haleon's return on invested capital was 7.9% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does Haleon have?

Haleon had total debt of £8.6 billion at the end of fiscal 2025, a debt-to-equity ratio of 0.52 and £7.3 billion of net debt (2.53 times EBITDA).

Does Haleon buy back its shares?

Yes. Haleon spent £639.7 million on net share repurchases in fiscal 2025.

What is Haleon's current ratio?

Haleon's current ratio was 0.92 at the end of fiscal 2025: current assets were 0.92 times current liabilities.

Drug Manufacturers - Specialty & Generic key metrics